中文产业新闻评分74Chinese source
三星生物制剂对瑞士多肽CDMO PolyPeptide公开要约收购获87.59%股份接受
120亿！三星生物拿下全球多肽CDMO巨头
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.
120亿！三星生物拿下全球多肽CDMO巨头
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.